Publishing Details
Contact & Outreach
About This Podcast
Explore Statistics
Recent Episodes
Innovations in Orphan Drugs for Rare Diseases
Novel modalities and the regulatory pathways to clear their journey to patients are driving developments in rare disease treatments in 2025. In this episode of the Drug Solutions podcast, Patrick…
Sustainable Solutions for Biopharma
Sustainability has been a recent focus of both pharmaceutical companies and stakeholders. In this episode of the Drug Solutions podcast, Patrick Lavery, editor for Pharmaceutical Technology®,…
Novel Drug Delivery Approaches: Refining AAV Vector Deliveries
Adeno-associated virus (AAV) vectors have become widely used as delivery mechanisms in gene therapy, but there are some complex hurdles to be overcome. In this episode of the Drug Solutions podcast,…
Equipment Trends for Addressing Production of New Modalities
In this episode of Drug Solutions, the discussion revolves around current and anticipated new trends in equipment and technologies for optimizing the manufacture of new biotherapeutic modalities,…
Forecasting Pharma’s Future
In this episode of the Drug Solutions podcast, Felicity Thomas, Associate Editorial Director, chats with a host of experts about the trends that have impacted the bio/pharma industry in 2024 and…
Realizing AI’s Potential
In this episode of the Drug Solutions podcast, Felicity Thomas, Associate Editorial Director, chats with a host of experts about artificial intelligence (AI) and the potential impact AI and machine…
Dosage Forms: Roundtable On Oral Solid Dosage Trends
Dosage forms, in particular oral solid dose, continue to evolve as new technologies enter the market, and as customer tastes and demands change. In this episode of the Drug Solutions podcast, Patrick…
Alternative Drug Delivery Methods for Biologics: Where Are We At?
The biopharmaceutical industry has long been working on methods to delivery biologic therapeutics in a manner that will enhance ease-of-use and patient compliance. Biologics today are largely…
Meeting Industry Needs: Fill/Finish Advances from a CDMO Perspective
In this sponsored episode, Jörg Zimmermann from Vetter chats about fill/finish advances.
Growth and Advancements in Fill/Finish
In this episode of the Drug Solutions podcast, Felicity Thomas, Associate Editorial Director, chats with Hanns-Christian Mahler, CEO and board member of ten23 health, about the growing demand for…
All About Data: Looking at the EHDS in More Detail
In this episode of the Drug Solutions podcast, Felicity Thomas, European/Senior Editor, chats with Alexander Natz, Secretary-General of EUCOPE, about the European Health Data Space (EHDS), which was…
A Closer Look at mRNA in Oncology and Vaccines
In this episode of the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for…
Applying Appropriate Analytics to Drug Development
In this episode of the Drug Solutions Podcast, industry experts give an overview of the biosimilars market and discuss factors affecting not only their manufacture, but their upstake in the market as…
The Biosimilars Landscape
In this episode of the Drug Solutions Podcast, industry experts give an overview of the biosimilars market and discuss factors affecting not only their manufacture, but their upstake in the market as…
Staying on Track with Formulation of Cell Culture Media
In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Tom Fletcher, director of Research and Development at FUJIFILM Irvine Scientific; and Bob Newman, PhD, chief…
Gliding Through the Ins and Outs of the Pharma Supply Chain
In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry,…
Digital Transformation in the Biopharma Industry
The trend toward digital transformation in biopharmaceutical manufacturing continues as advanced technologies enter the scene and work their way through to manufacturing operations. With the…
Starting Up in the CGT Manufacturing Space
In this episode of the Drug Solutions Podcast, Shawn Liu, the president and CEO of Avirmax, relates his experience in entering the cell and gene therapy manufacturing space and how he began his own…
Breaking Through the Barriers of Drug Development
Dr. Graziella Piras, senior director of Strategic Marketing at 908 Devices, discusses drug development, specifically about monitoring bioprocess parameters and other important technologies important…
mRNA Past, Present, and Future
Chris Spivey, editorial director, hosts a wide ranging discussion on the COVID-19 pandemic response, future government communications, and healthcare funding for mRNA with experts Dr. Kate Broderick,…
Frequently Asked Questions
Drug Solutions has published 56 episodes since January 2022, covering topics in Science.
Drug Solutions is currently declining with new episodes monthly. Average episode length is 22m.
Sign up on Grep.FM to access contact details for Drug Solutions, including email and social media links.
